- Home
- XFOR vs BMRC Comparison
XFOR vs BMRC Comparison
Compare XFOR & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | BMRC |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | 45 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.3M | 417.9M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | XFOR | BMRC |
|---|---|---|
| Price | $4.37 | $28.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.00 | ★ $28.67 |
| AVG Volume (30 Days) | ★ 1.0M | 169.7K |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $391.81 |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | ★ N/A | $53.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $21.77 |
| 52 Week High | $4.83 | $30.34 |
Technical Indicators
Market Signals| Indicator | XFOR | BMRC |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 65.37 |
| Support Level | $3.50 | $25.25 |
| Resistance Level | $4.41 | $30.34 |
| Average True Range (ATR) | 0.29 | 0.92 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 60.47 | 59.31 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.